Medicus Pharma (MDCX) news
Recent news
Medicus Pharma - Announces fifty-to-one share consolidation effective October 12, 2026 - SEC filing
AInvest Wire · 7d agoMedicus Pharma - Terminates standby equity purchase agreement with Yorkville effective Sept 11, 2026 - SEC filing
Medicus Pharma Ltd. (MDCX) has announced the termination of its standby equity purchase agreement with Yorkville, effective September 11, 2026, as disclosed in a recent SEC filing . The agreement, which had previously facilitated a $3,846,910 equity raise for the company, is now formally concluded.…
AInvest Wire · Sep 14, 2026Medicus Pharma - CD228V established as principal strategic priority for Medicus Pharma
AInvest Wire · Sep 8, 2026Medicus Pharma advances transformation into a precision oncology-led biotechnology company
AInvest Wire · Sep 8, 2026Medicus Pharma shares down 29.8%; co, Pfizer enter licensing deal for experimental cancer therapy
Medicus Pharma Ltd. (MDCX) shares fell 29.8% in early trading on September 3, 2026, following the company’s announcement of a licensing agreement with Pfizer for an experimental cancer therapy. The deal involves the development and commercialization of CD228V, an investigational treatment. The…
AInvest Wire · Sep 3, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.